Townsend Adam J. 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 30, 2025
Insider Transaction Report
Form 4
Townsend Adam J.
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-01-29$29.52/sh−695$20,519→ 84,050 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 28, 2025.